Takara Bio Inc. (TYO:4974)
Japan · Delayed Price · Currency is JPY 797.00
-19.00 (-2.33%)
At close: Feb 6, 2026
Takara Bio Market Cap
Takara Bio has a market cap or net worth of 95.97 billion as of February 6, 2026. Its market cap has decreased by -20.14% in one year.
Market Cap
95.97B
Enterprise Value
85.20B
Revenue
44.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
797.00
Market Cap Chart
Since December 7, 2004, Takara Bio's market cap has increased from 54.50B to 95.97B, an increase of 76.11%. That is a compound annual growth rate of 2.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 98.26B | 2.64% |
| Dec 30, 2025 | 95.73B | -24.29% |
| Dec 30, 2024 | 126.44B | -16.13% |
| Dec 29, 2023 | 150.76B | -27.34% |
| Dec 30, 2022 | 207.48B | -34.83% |
| Dec 30, 2021 | 318.38B | -4.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PeptiDream | 198.67B |
| SanBio Company | 149.67B |
| GNI Group | 142.90B |
| Nxera Pharma | 76.74B |
| Cuorips | 67.65B |
| Oncolys BioPharma | 52.05B |
| Healios K.K. | 44.09B |
| RaQualia Pharma | 26.01B |